The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes.
COVID-19 lockdown
Children and adolescents
Continuous glucose monitoring
Glycemic control
Type 1 diabetes
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
19 01 2022
19 01 2022
Historique:
received:
17
05
2021
accepted:
10
01
2022
entrez:
20
1
2022
pubmed:
21
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
Between March 18 In this retrospective register study from a pediatric diabetes outpatient clinic, we analyzed the glycemic data of T1D patients (n = 245; aged 4 to 16 years) before and under the lockdown. All the participants used continuous glucose monitoring (rtCGM or iCGM), two-thirds were on insulin pumps (CSII), and one-third on multiple daily insulin injections (MDI) therapy. In our patient cohort, time in range (TIR, n = 209) and mean glucose levels (n = 214) were similar prior to and under the lockdown (mean change 0.44% [95%CI: -1.1-2.0], p = 0.56 and -0.13 mmol/mol [95%CI: -0.3-0.1], p = 0.17, respectively). However, children treated with CSII improved their glycemic control significantly during the lockdown: TIR improved on average 2.4% [0.6-4.2] (p = 0.010) and mean blood glucose level decreased -0.3 mmol/mol [-0.6-(-0.1)] (p = 0.008). The difference was more pronounced in girls, adolescents and patients using conventional insulin pumps. The glycemic control in T1D children did not deteriorate under the lockdown, and patients on CSII even improved their control, which suggests that social distancing might have allowed families to use the insulin pump more accurately as out-of-home activities were on hold.
Sections du résumé
BACKGROUND
Between March 18
METHODS
In this retrospective register study from a pediatric diabetes outpatient clinic, we analyzed the glycemic data of T1D patients (n = 245; aged 4 to 16 years) before and under the lockdown. All the participants used continuous glucose monitoring (rtCGM or iCGM), two-thirds were on insulin pumps (CSII), and one-third on multiple daily insulin injections (MDI) therapy.
RESULTS
In our patient cohort, time in range (TIR, n = 209) and mean glucose levels (n = 214) were similar prior to and under the lockdown (mean change 0.44% [95%CI: -1.1-2.0], p = 0.56 and -0.13 mmol/mol [95%CI: -0.3-0.1], p = 0.17, respectively). However, children treated with CSII improved their glycemic control significantly during the lockdown: TIR improved on average 2.4% [0.6-4.2] (p = 0.010) and mean blood glucose level decreased -0.3 mmol/mol [-0.6-(-0.1)] (p = 0.008). The difference was more pronounced in girls, adolescents and patients using conventional insulin pumps.
CONCLUSIONS
The glycemic control in T1D children did not deteriorate under the lockdown, and patients on CSII even improved their control, which suggests that social distancing might have allowed families to use the insulin pump more accurately as out-of-home activities were on hold.
Identifiants
pubmed: 35045807
doi: 10.1186/s12887-022-03115-6
pii: 10.1186/s12887-022-03115-6
pmc: PMC8766349
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
48Informations de copyright
© 2022. The Author(s).
Références
Diabetes Care. 2012 Jun;35(6):1219-24
pubmed: 22474040
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1621-1623
pubmed: 32889403
Acta Diabetol. 2021 Jul;58(7):959-961
pubmed: 33721077
Diabetes Technol Ther. 2020 Jun;22(6):462-467
pubmed: 32421355
Acta Diabetol. 2021 May;58(5):661-664
pubmed: 33532867
Front Endocrinol (Lausanne). 2020 Dec 07;11:595735
pubmed: 33424771
J Diabetes Investig. 2021 Sep;12(9):1708-1717
pubmed: 33539665
Healthcare (Basel). 2021 Jun 28;9(7):
pubmed: 34203306
Diabetes Care. 2019 Nov;42(11):2050-2056
pubmed: 31488568
J Pediatr Endocrinol Metab. 2013;26(11-12):1083-6
pubmed: 23740676
Acta Diabetol. 2020 Dec;57(12):1511-1517
pubmed: 33026497
J Adv Nurs. 2011 Oct;67(10):2096-108
pubmed: 21635284
Acta Paediatr. 2021 Jul;110(7):2206-2207
pubmed: 33709538
Diabetes Res Clin Pract. 2020 Aug;166:108307
pubmed: 32650036
Diabetes Care. 2019 Jan;42(Suppl 1):S148-S164
pubmed: 30559239
BMJ Open Diabetes Res Care. 2020 Oct;8(2):
pubmed: 33115820
Diabetes Ther. 2020 May 11;:1-11
pubmed: 32395187
Diabetes Res Clin Pract. 2020 Aug;166:108348
pubmed: 32711000
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33431602
Obesity (Silver Spring). 2020 Aug;28(8):1382-1385
pubmed: 32352652
Diabetes Res Clin Pract. 2020 Aug;166:108302
pubmed: 32623034
J Phys Act Health. 2015 Feb;12(2):232-7
pubmed: 24508755